• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    5/12/23 1:09:06 PM ET
    $AIRS
    $AKU
    $ARLO
    $ARRY
    Medical/Nursing Services
    Health Care
    Medical Specialities
    Health Care
    Get the next $AIRS alert in real time by email

    Gainers

    • GSI Technology, Inc. (NASDAQ:GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16, 2023.
    • ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) shares jumped 82.8% to $8.27 after the company reported the FDA's Advisory Committee voted in support of favorable benefit-risk assessment for neffy in the treatment of severe allergic reactions (Type 1), including anaphylaxis.
    • Getaround, Inc. (NYSE:GETR) shares climbed 73.6% to $0.5749 after the company announced it is acquiring substantially all of the assets of HyreCar for an aggregate purchase price of $9.45 million.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares climbed 45.1% to $2.80 after the company highlighted recent corporate progress, and reported financial results for the first quarter.
    • Jupiter Wellness Acquisition Corp. (NASDAQ:JWAC) surged 40% to $7.10.
    • Blue Bird Corporation (NASDAQ:BLBD) gained 38.7% to $26.80 after the company reported better-than-expected Q2 results.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) shares climbed 32.8% to $6.50 after the company reported better-than-expected Q1 financial results.
    • Arlo Technologies, Inc. (NASDAQ:ARLO) gained 24.3% to $8.76 following strong quarterly results.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) rose 23.2% to $0.77.
    • First Solar, Inc. (NASDAQ:FSLR) surged 21.9% to $223.36 after the company announced the acquisition of Evolar.
    • Ouster, Inc. (NYSE:OUST) gained 19.3% to $4.58 following strong Q1 sales results.
    • VYNE Therapeutics Inc. (NASDAQ:VYNE) gained 19.3% to $7.28 after the company reported Q1 financial results.
    • Array Technologies, Inc. (NASDAQ:ARRY) jumped 18.6% to $22.47 following strong quarterly results.
    • SurgePays, Inc. (NASDAQ:SURG) gained 14.7% to $5.06 after the company reported Q1 financial results.
    • Pharming Group N.V. (NASDAQ:PHAR) rose 14.5% to $11.69. Pharming recently posted a Q1 loss of $0.02 per share.
    • P3 Health Partners Inc. (NASDAQ:PIII) jumped 14.3% to $2.64. P3 Health Partners recently posted upbeat quarterly results.
    • Holley Inc. (NYSE:HLLY) gained 12.8% to $3.07. Telsey Advisory Group and Raymond James raised their price targets on the stock.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) rose 9.3% to $1.29 following better-than-expected quarterly sales.
    • Hallmark Financial Services, Inc. (NASDAQ:HALL) gained 9.1% to $4.31.
    • News Corporation (NASDAQ:NWS) surged 6.7% to $17.97 following Q3 results.

    Losers

    • Assure Holdings Corp. (NASDAQ:IONM) fell 37.8% to $1.20 after the company announced pricing of a $6 million underwritten public offering.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) dropped 33.9% to $1.4750 after the company reported mixed Q1 financial results.
    • TOP Financial Group Limited (NASDAQ:TOP) shares fell 29.7% to $6.42 after the SEC said it is temporarily suspending trading in the securities of the company because of "recent, unusual, and unexplained market activity" raising concerns regarding the adequacy and accuracy of publicly-available information.
    • AVITA Medical, Inc. (NASDAQ:RCEL) dropped 24.3% to $11.89 after the company reported mixed Q1 financial results.
    • Freight Technologies, Inc. (NASDAQ:FRGT) declined 23% to $1.54 after the company reported preliminary Q1 2023 revenue of $3.3 million, down from $5.3 million for Q1 prior year 2022.
    • Intrusion Inc. (NASDAQ:INTZ) dropped 22.9% to $1.31 following weak quarterly results.
    • BitNile Metaverse, Inc. (NASDAQ:BNMV) fell 22.3% to $0.0449 after the company announced a 1-for-30 reverse stock split.
    • Audacy, Inc. (NYSE:AUD) dropped 20.6% to $0.1086. Audacy recently reported mixed Q1 financial results.
    • Impel Pharmaceuticals Inc. (NASDAQ:IMPL) fell 19.7% to $1.83 after the company reported a decrease in year-over-year Q1 EPS results and worse-than-expected Q1 sales results.
    • Check-Cap Ltd. (NASDAQ:CHEK) dropped 19% to $1.49 following a wider-than-expected quarterly loss.
    • Dingdong (Cayman) Limited (NYSE:DDL) fell 18.7% to $3.2820 after the company reported worse-than-expected Q1 sales results.
    • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) fell 18.5% to $6.74.
    • Akumin Inc. (NASDAQ:AKU) dipped 18.4% to $0.4260. Akumin recently posted a wider quarterly loss.
    • ImmunityBio, Inc. (NASDAQ:IBRX) dropped 18% to $2.2850 after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $10 to $4.
    • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) dipped 17% to $6.86.
    • Cemtrex, Inc. (NASDAQ:CETX) fell 16.5% to $9.10 after the company reported Q2 results.
    • Harrow Health, Inc. (NASDAQ:HROW) dropped 16.3% to $22.66 after the company reported Q1 financial results.
    • VCI Global Limited (NASDAQ:VCIG) fell 14.8% to $3.00 after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.
    • Youdao, Inc. (NYSE:DAO) dropped 14.4% to $5.42.
    • OraSure Technologies, Inc. (NASDAQ:OSUR) fell 13.8% to $6.37. OraSure Technologies recently posted upbeat quarterly results.
    • Emergent BioSolutions Inc. (NYSE:EBS) dropped 12.5% to $9.19. Emergent BioSolutions recently reported better-than-expected Q1 sales results.
    • Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) declined 10.6% to $8.27. Marinus Pharmaceuticals reported Q1 financial results.
    • IonQ, Inc. (NYSE:IONQ) shares fell 9.8% to $6.32 after the quantum computing company reported first-quarter financial results.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares dropped 9.7% to $0.7210. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.
    • Definitive Healthcare Corp. (NASDAQ:DH) dropped 9% to $8.89.
    • MMTec, Inc. (NASDAQ:MTC) fell 8.2% to $1.01 after gaining more than 5% on Thursday.
    • Unique Fabricating, Inc. (NASDAQ:UFAB) fell 7.4% to $0.2453 after dropping 16% on Thursday.
    • IHS Holding Limited (NYSE:IHS) dropped 7.3% to $8.40.
    • BIOLASE, Inc. (NASDAQ:BIOL) shares dropped 6.8% to $0.2236 after the company posted Q1 results.

     

    Now Read This: Bitcoin Tumbles Below This Key Level Following Economic Data; Pepe, Huobi Token Among Top Losers

    Get the next $AIRS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIRS
    $AKU
    $ARLO
    $ARRY

    CompanyDatePrice TargetRatingAnalyst
    Array Technologies Inc.
    $ARRY
    10/2/2025$9.00Overweight → Equal Weight
    Barclays
    Array Technologies Inc.
    $ARRY
    9/30/2025$11.00Outperform
    Robert W. Baird
    Array Technologies Inc.
    $ARRY
    9/30/2025$11.00Buy
    Deutsche Bank
    IonQ Inc.
    $IONQ
    9/15/2025$60.00 → $80.00Buy
    Needham
    Array Technologies Inc.
    $ARRY
    9/12/2025$7.00Neutral → Underperform
    BofA Securities
    ARS Pharmaceuticals Inc.
    $SPRY
    9/4/2025$40.00Buy
    Roth Capital
    P3 Health Partners Inc.
    $PIII
    8/28/2025$20.00Buy
    Lake Street
    IonQ Inc.
    $IONQ
    8/27/2025$61.00Buy
    B. Riley Securities
    More analyst ratings

    $AIRS
    $AKU
    $ARLO
    $ARRY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Array Tech downgraded by Barclays with a new price target

    Barclays downgraded Array Tech from Overweight to Equal Weight and set a new price target of $9.00

    10/2/25 8:36:38 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Robert W. Baird initiated coverage on Array Tech with a new price target

    Robert W. Baird initiated coverage of Array Tech with a rating of Outperform and set a new price target of $11.00

    9/30/25 8:42:19 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Deutsche Bank initiated coverage on Array Tech with a new price target

    Deutsche Bank initiated coverage of Array Tech with a rating of Buy and set a new price target of $11.00

    9/30/25 8:42:19 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mcnamara Robert bought $45,000 worth of shares (10,000 units at $4.50), increasing direct ownership by 13% to 86,771 units (SEC Form 4)

    4 - AVITA Medical, Inc. (0001762303) (Issuer)

    8/29/25 4:30:09 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    CFO O'Toole David D bought $9,040 worth of shares (2,000 units at $4.52), increasing direct ownership by 7% to 31,657 units (SEC Form 4)

    4 - AVITA Medical, Inc. (0001762303) (Issuer)

    8/26/25 4:30:23 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    Director Mcnamara Robert bought $50,000 worth of shares (10,000 units at $5.00), increasing direct ownership by 15% to 76,771 units (SEC Form 4)

    4 - AVITA Medical, Inc. (0001762303) (Issuer)

    8/20/25 6:11:04 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Heller Casey covered exercise/tax liability with 8,300 shares, decreasing direct ownership by 0.76% to 1,081,421 units (SEC Form 4)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    10/3/25 8:23:35 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Coop Kevin covered exercise/tax liability with 37,593 shares, decreasing direct ownership by 1% to 3,584,788 units (SEC Form 4)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    10/3/25 8:20:47 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    CEO Mcrae Matthew Blake converted options into 178,094 shares and sold $1,621,566 worth of shares (95,430 units at $16.99), increasing direct ownership by 5% to 1,747,591 units (SEC Form 4)

    4 - Arlo Technologies, Inc. (0001736946) (Issuer)

    10/2/25 9:26:16 PM ET
    $ARLO
    Consumer Electronics/Appliances
    Consumer Staples

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic

    SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it has received an award valued up to $339M from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The multi-year agreement consists of a Base contract with Option periods. The Base period funding of $58M over 24 months supports the onshoring of CD388 manufacturing to the United States as an addition to the initial commerc

    10/2/25 4:01:00 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    One in Five Homes Slashes Prices in September, Realtor.com® Reports

    As inventory rises for the 23rd straight month, lower- and mid-tier sellers adjust prices to stay competitive AUSTIN, Texas, Oct. 2, 2025 /PRNewswire/ -- Nearly one in five homes saw a price reduction in September, as rising inventory gives buyers more negotiating power, according to the Realtor.com® September Monthly Housing Trends report. Sellers of homes at the lower- and mid-tier are the most likely to adjust their asking price, while luxury home prices remain largely untouched, with reductions least common at the top of the market. "September's trends show a housing market increasingly tilting in buyers' favor, with a rising inventory of homes for sale, longer days on market and more c

    10/2/25 6:00:00 AM ET
    $NWS
    $NWSA
    Newspapers/Magazines
    Consumer Discretionary

    VCI Global to Announce First Half 2025 Financial Results on October 6, 2025

    KUALA LUMPUR, Malaysia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ:VCIG) ("VCI Global" or the "Company"), today announced that it will release its financial results for the six months ended June 30, 2025, before the U.S. markets open on Monday, October 6, 2025. The Company's management team will host an earnings call at 8:30 a.m. Eastern Time on the same day to discuss the financial performance and provide updates on its strategic initiatives and outlook for the remainder of 2025. Participants are encouraged to dial in at least 10 minutes before the scheduled start time. To access the call, please register via the following link to receive the dial-in number and unique

    10/1/25 3:30:00 PM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    $AIRS
    $AKU
    $ARLO
    $ARRY
    SEC Filings

    View All

    SurgePays Inc. filed SEC Form 8-K: Leadership Update

    8-K - SurgePays, Inc. (0001392694) (Filer)

    10/2/25 4:08:47 PM ET
    $SURG
    Advertising
    Consumer Discretionary

    SEC Form 144 filed by Arlo Technologies Inc.

    144 - Arlo Technologies, Inc. (0001736946) (Subject)

    10/2/25 3:50:49 PM ET
    $ARLO
    Consumer Electronics/Appliances
    Consumer Staples

    Amendment: SEC Form SCHEDULE 13D/A filed by ARS Pharmaceuticals Inc.

    SCHEDULE 13D/A - ARS Pharmaceuticals, Inc. (0001671858) (Subject)

    10/1/25 9:19:13 PM ET
    $SPRY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by First Solar Inc.

    SC 13D - FIRST SOLAR, INC. (0001274494) (Subject)

    12/10/24 1:11:10 PM ET
    $FSLR
    Semiconductors
    Technology

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Financials

    Live finance-specific insights

    View All

    Dow Jones Acquires Eco-Movement

    Latest acquisition advances Dow Jones's energy business with industry-leading data Dow Jones today announced it has acquired Eco-Movement, a leading global platform for EV charging station data. Eco-Movement will operate as part of OPIS, Dow Jones's growing energy business. Headquartered in Utrecht, Netherlands, Eco-Movement is a leading charge point data platform. The company collects, optimizes and enriches EV charging station data, and has built an extensive data platform with public and semi-public EV charging points and their real-time availability. Its platform features almost 2 million connectors across more than 80 countries and adds to Dow Jones's suite of energy products and s

    9/18/25 9:50:00 AM ET
    $NWS
    $NWSA
    Newspapers/Magazines
    Consumer Discretionary

    Dingdong (Cayman) Limited Announces Second Quarter 2025 Financial Results

    SHANGHAI, Aug. 21, 2025 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced its unaudited financial results for the quarter ended June 30, 2025. Second Quarter 2025 Highlights:  GMV for the second quarter of 2025 increased by 4.5% year over year to RMB6,499.4 million (US$907.3 million) from RMB6,218.7 million in the same quarter of 2024, positive year-on-year growth for six straight quarters.Total number of orders increased by 5.5% year over year in the second quarter of 2025.Net income for the second quarter of 2025 increased by 59.7% year over year

    8/21/25 5:30:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    Dingdong to Report Second Quarter 2025 Financial Results on August 21, 2025

    SHANGHAI, Aug. 18, 2025 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before U.S. markets open on August 21, 2025. The Company will hold an earnings conference call at 8:00 A.M. Eastern Time on Thursday, August 21, 2025 (8:00 P.M. Beijing Time on the same day) to discuss its financial results. Management's prepared remarks and the question-and-answer session will be conducted in English and Mandarin. Dial-in details for the earnings conference call a

    8/18/25 7:00:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AIRS
    $AKU
    $ARLO
    $ARRY
    Leadership Updates

    Live Leadership Updates

    View All

    IonQ Appoints General John W. "Jay" Raymond to Board of Directors

    "Father of the U.S. Space Force" and former Chief of Space Operations brings nearly four decades of national security and leadership experience to IonQ IonQ (NYSE: IONQ), the leader in the quantum computing and networking industries, today announced the appointment of General John W. "Jay" Raymond to its Board of Directors. A globally recognized leader in space and national security operations, General Raymond most recently served as the first Chief of Space Operations for the U.S. Space Force. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250929352806/en/President Donald J. Trump shakes General John W. "Jay" Raymond's hand a

    9/29/25 7:05:00 AM ET
    $IONQ
    EDP Services
    Technology

    ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair

    – Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of their innovations – SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, today announced the appointment of Laura Shawver, Ph.D., as Chair of its Board of Directors. "We are honored to welcome Dr. Shawver to our Board. Laura's outstanding track record of driving strategic growth and developing innovative therapies comes at a pivotal time as we scale to advance our pipeline and expand the impact of our next-generation

    9/17/25 9:00:00 AM ET
    $SPRY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IonQ Appoints Dean Acosta as Chief Corporate Affairs and Government Relations Officer

    Acosta Brings Significant Communications and Public Service Experience IonQ (NYSE:IONQ), the leader in the quantum computing and networking industries, today announced the appointment of Dean Acosta as Chief Corporate Affairs and Government Relations Officer. In this new position for IonQ, Acosta will oversee all corporate and government affairs activities, reporting directly to Niccolo de Masi, Chairman and CEO of IonQ. Acosta's appointment reflects the ongoing strategic evolution of IonQ's leadership team and commitment to expanding its capabilities across critical business functions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/

    9/10/25 7:05:00 AM ET
    $IONQ
    EDP Services
    Technology